<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cyclin-dependent kinase (cdk) inhibitor p27 preferentially inactivates cdk complexes required for progression through the G1/S transition </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of p27 is associated with <z:hpo ids='HP_0000718'>aggressive behavior</z:hpo> in a variety of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, including Barrett's associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (BAA) </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously shown that gastroduodenal-<z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">esophageal reflux</z:e> (GDER) together with N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-N-benzylnitrosamine (MBN) induces <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) and <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of the esophageal mucosa in mice </plain></SENT>
<SENT sid="3" pm="."><plain>This process is enhanced in a p27 null background </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we show that <z:hpo ids='HP_0011010'>chronic</z:hpo> flavopiridol administration sharply reduced the prevalence of BE in GDER/MBN-treated p27 knockout mice when compared to animals treated with diluent only (7 vs 26%, P=0.0079) </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, flavopiridol reduced the prevalence of BAA (11 vs 32%, P=0.0098) and overall <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevalence (15 vs 60%, P&lt;0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, appropriate molecular targeting by flavopiridol in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells was confirmed by downregulation of cyclin D1, a known target of this pan-cdk inhibitor </plain></SENT>
<SENT sid="7" pm="."><plain>The results of this study represent the experimental basis for chemoprevention with cdk inhibitors in human BE and BAA </plain></SENT>
</text></document>